Real-time enrollment status for this atopic dermatitis (ad) clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 6:17 PM UTC
| NCT Number | NCT07298395 |
| Recruiting Status | Recruiting |
| Condition | Atopic Dermatitis (AD) |
| Phase | PHASE2 |
| Target Enrollment | 60 participants |
| Active Locations | 32 sites in the US |
| Sponsor | Enveda Therapeutics |
| Last Updated on CT.gov | July 29, 2026 (4 weeks ago) |
As of August 27, 2026: Clinical trial NCT07298395 is currently recruiting participants. This phase2 study for atopic dermatitis (ad) is actively seeking new participants at 32 locations across the United States. The study is sponsored by Enveda Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07298395 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 32 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07298395 was last updated 4 weeks ago (July 29, 2026). HelloStudys verifies this status automatically.